Dr. Robert A. Barish, a distinguished physician and academic leader, is vice chancellor for health affairs of the University of Illinois at Chicago.

He oversees the University of Illinois Hospital & Health Sciences System (UI Health), which provides comprehensive care, education, and research to train healthcare leaders and foster healthy communities in Illinois and beyond. A part of the University of Illinois at Chicago (UIC), UI Health comprises a clinical enterprise that includes a 465-bed tertiary care hospital, 21 outpatient clinics, and 11 Mile Square Health Center facilities, which are Federally Qualified Health Centers. With campuses in Chicago, Peoria, Quad Cities, Rockford, Springfield, and Urbana, the health system includes the academic and research activities of the seven UIC health sciences colleges: Applied Health Sciences, Dentistry, Medicine, Nursing, Pharmacy, the School of Public Health, and the Jane Addams College of Social Work.

Previously, Dr. Barish served as chancellor of the LSU Health Sciences Center at Shreveport from 2009 to 2015, where he provided leadership for the schools of medicine, allied health, and graduate programs, a major academic medical center, and two affiliated hospitals.

Dr. Barish spent 24 years at the University of Maryland School of Medicine. He served as chief of emergency medicine from 1985 to 1996 and built a nationally recognized program. There he was named associate dean for clinical affairs in 1998 and eventually became vice dean for clinical affairs in 2005. 

That same year, following the devastation of Hurricane Katrina on the Gulf Coast, Dr. Barish helped lead a medical regiment dispatched by the state of Maryland to deliver emergency care to more than 6,000 hurricane victims in Jefferson Parish, Louisiana.

In addition to his medical duties at Maryland, Dr. Barish earned an MBA from Loyola College in 1995. From 1996 to 1998, he served as the chief executive officer of UniversityCARE, a University of Maryland physician-hospital network of family-oriented health centers located in neighborhoods throughout the Baltimore metropolitan area.

A former lieutenant colonel and flight surgeon in the Maryland Air National Guard, Barish was among a select group invited to become a NASA astronaut candidate in the early 1990s.

After earning his medical degree from New York Medical College in 1979, Dr. Barish interrupted his residency training for one year to provide medical treatment to refugees at camps along the Thai-Cambodian border and in Somalia. He completed an internal medicine residency at New York’s Saint Vincent’s Hospital and Medical Center in 1983 and an emergency medicine residency at Georgetown University Medical Center in 1985. He is a member of Alpha Omega Alpha Medical Honor Society, a fellow of the American College of Emergency Physicians and the American Academy of Emergency Medicine, and is on the Board of Directors for the Association of Academic Health Centers.

Dr. Jean M. Malecki began her work as director of the Palm Beach County Health Department with a vision of making Palm Beach County the healthiest community in the nation, and over the course of her 19 year career, went on to initiate a local public health system dedicated to serving the entire community by utilizing partnerships from every entity.

A South Florida native, Dr. Malecki’s training began at Fairfield University in Connecticut where she obtained a Bachelor of Science Degree with pre-medical honors, and a medical degree from New York Medical College where she graduated with honors including membership in the Alpha Omega Alpha Honor Society, Cor Et Manus Service Society and American Women's Citation for Scholastic Achievement in Medicine. She earned a Master of Public Health Degree from the University of Miami. Dr. Malecki is board certified in general preventive medicine and public health, and is a fellow of the American Board of Preventive Medicine and Public Health, and an alumnus of the Public Health Leadership Institute.

In 1982, when HIV/AIDS was an emerging disease in Palm Beach County, Dr. Malecki diagnosed one of the first children with AIDS and helped form the Comprehensive AIDS Program, a 501c3, initially started with one of the first Robert Wood Johnson Grants Foundation for this disease. This program now serves over 7,000 people living with HIV/AIDS in the County.

In the mid-1990s, Dr. Malecki formed the Maternal Child Health Alliance and became its first president. Soon after, she helped create the Healthy Start, an off-shoot of the Maternal Child Health Allicance, which provides in-home counseling to pregnant women and follow-up care for mother and baby. Today, Palm Beach County maintains one of the lowest infant mortality rates in the United States.

In 2001, Dr. Malecki received international attention for her assistance in the diagnosis and public Health intervention of the first case of intentional Anthrax, successfully leading the investigation for the State of Florida.

In 2002, when citizens of Palm Beach County voted to create the Health Care District of Palm Beach County to guarantee funding for health care and trauma services,Dr. Malecki served on the Board of Directors and helped initiate the Palm Beach County-Wide Trauma System.. In addition, with funding through the District’s insurance programs, Dr. Malecki expand the primary care clinics within the Health Department—adding four new clinic buildings, an administrative complex, a hospital and county nursing home.

Many of the programs instituted under Dr. Malecki’s leadership have become models for local public health systems throughout the nation, including: the Hospital Emergency Response Coalition, formed to unify the private hospitals in the event of a disaster; Protocol for Assessing Community Excellence in Environmental Health, to provide environmental support to communities in need of better water, air and land systems; and Community Health Division to forge public/private partnerships. Much of this has been accomplished through Dr. Malecki’s foresight in making the Palm Beach County Health Department an Academic Health Department that is constantly learning, teaching, and creating innovative ways to better serve the public’s health.

Dr. Malecki has been identified as "Changing the Face of Medicine" and a Local Legend by the National Library of Medicine. She has been named one of the top 25 Faces of Public Health by the American Public Health Association and a Woman of Distinction by the Women’s Chamber of Commerce. She is a recipient of a Presidential Citation for her leadership in curtailing the risk from bioterrorism. 

Dr. Ira D. Glick joined the faculty of the Stanford University School of Medicine in July, 1993. Prior to that, he served as professor of Psychiatry at the University of California, San Francisco (UCSF) from 1968 to 1978 and at the Cornell University Medical College from 1978 to 1993. During his tenure at Cornell, he was also senior science advisor to the director of the National Institute of Mental Health. Dr. Glick’s research has focused on the effectiveness of psychiatric hospitalization, the current and future treatment of schizophrenia and mood disorders including combining medication and psychotherapy (both individual as well as family therapy) and the diagnosis and treatment of athletes.

A 1961 graduate of New York Medical College, Dr. Glick is a Distinguished Fellow of the American Psychiatric Association, a founding member of the American Family Therapy Academy, the International Society of Sports Psychiatry (ISSP) and founding and long-time member of the Board of Directors of the American Society of Clinical Psychopharmacology (ASCP). Dr. Glick has been elected to membership of the American College of Neuropsychopharmacology (ACNP) and the American College of Psychiatrists.　

He has authored or co-authored more than 200 articles published in the scientific literature and wrote or edited ten books on mental/psychiatric illness, psychopharmacology, family therapy, and recently sports psychiatry. He is a long-time editor of the American Society Clinical Psychopharmacology Model Psychopharmacology Curriculums with separate publications for teachers of psychiatric residents and another for both medical students and primary care clinician.　

Dr. Glick has received numerous national and international awards for his research and teaching including those from the American Psychiatric Association, American College of Neuropsychopharmacology (ACNP) and the Association of Academic Psychiatry. He received the 2014 Kum Po Soo Award from the American Psychiatric Association,  as well as an "exemplary psychiatrist" award from the National Alliance for Mental Illnesses (NAMI). In 2017, he received the Dean Award from the American College of Psychiatrists for his research in Schizophrenia. In 2019 he received the Payne Whitney Clinic Award for Extraordinary Public Service for a distinguished researcher, clinician, and educator, "who has transformed the field with his innovative treatment approaches to schizophrenia and his dedication to the dissemination of knowledge ."

Dr. Glick was appointed emeritus professor at Stanford in 2010. He is now, visiting professor at three medical schools- Weill Cornell Medical College, New York University and University California San Diego –and has recently rejoined the adjunct faculty at University California San Francisco.　

In 2018, he served on the International Olympic Consensus Committee, focusing on "Mental Health in Elite Athletes." He was also a commentator in the 20-hour, 2018 ESPN documentary, "Basketball: A Love Story."

Leonard S. Schleifer, M.D., Ph.D., founded Regeneron in 1988, and has served as president, and chief executive officer since its inception. Dr. Schleifer, together Regeneron’s president and chief scientific officer, George Yancopoulos, M.D., Ph.D. has built the company from a small startup into one of the world’s leading biotechnology companies, with a unique science-driven culture.

Regeneron’s ability to consistently translate science into medicine has led to seven FDA-approved treatments and twenty product candidates, all of which were homegrown in its laboratories. Regeneron’s medicines and pipeline are designed to help patients with eye disease, heart disease, allergic and inflammatory diseases, pain, cancer, infectious diseases and rare diseases.

The company is accelerating and improving the traditional drug development process through its proprietary technologiesto yield optimized, fully-human antibodies, and ambitious initiatives such as the Regeneron Genetics Center, one of the largest genetics sequencing efforts in the world.

Dr. Schleifer has been recognized as one of Barron’s Best CEOs, a Yale School of Management Legend in Leadership and as Ernst & Young’s’ Life Sciences Entrepreneur of the Year. Under his leadership, Regeneron has been repeatedly voted the number one company to work for in the biopharmaceutical industry by Science magazine and has been consistently ranked a top ten most innovative company by Forbes.

Dr. Schleifer graduated Phi Beta Kappa and summa cum laude from Cornell University and earned his M.D. and Ph.D. in pharmacology from the University of Virginia. He is a licensed physician, certified in Neurology by the American Board of Psychiatry and Neurology.

George D. Yancopoulos, M.D., Ph.D., co-founder, president and chief scientific officer of Regeneron, has worked to build Regeneron into a leader in science-driven biotechnology. Under Dr. Yancopoulos’ direction, Regeneron’s accomplishments include the invention and development of seven FDA-approved medicines for cancer, vision-threatening eye diseases, heart disease, atopic dermatitis, asthma and rheumatoid arthritis.
Dr. Yancopoulos, along with his team, co-invented Regeneron's foundational technologies for target and drug discovery. He continues to be a force in biotech innovation and led the creation of the Regeneron Genetics Center which has sequenced the exomes of more than 500,000 people. Regeneron routinely appears on Forbes list of the Most Innovative Companies in the World.

Dr. Yancoppulos graduated valedictorian from the Bronx High School of Science (where he was a Westinghouse Science Talent Search winner) and Columbia University where he received his M.D. and Ph.D. in biochemistry and molecular biophysics. He was the first graduate student of the renowned molecular immunologist, Fred Alt, Ph.D. He was pursuing a career in academia when he met and joined his Regeneron co-founder Leonard S. Schleifer, M.D., Ph.D.

Dr. Yancopoulos has authored more than 300 papers, holds more than 100 patents and was among the ten most highly cited scientific authors in the world during the 1990s. He was elected to the National Academy of Sciences in 2004, was inducted into the Biotech Hall of Fame in 2014 and was named Ernst & Young’s Entrepreneur of the Year in 2016, along with Dr. Schleifer. He is passionate about inspiring young talent to pursue scientific careers through numerous STEM and internship programs. Under his leadership, Regeneron has taken on sponsorship of the nation’s oldest and most prestigious high school science competition, formerly sponsored by Westinghouse and Intel, and now known as the Regeneron Science Talent Search.